Is there evidence supporting the nephrotoxicity of sumatriptan in patients with migraine?
No direct evidence for nephrotoxicity of sumatriptan in patients with migraine was identified. Limited human case reports suggest potential nephrotoxic risks, particularly in patients with compromised kidney function or using concurrent vasoactive drugs.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-13
- DOI
- https://doi.org/10.5281/zenodo.24201641
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00